Highlights Kyowa Kirin Co., Ltd. OTC Markets

Equities

Delayed OTC Markets Other stock markets 14:50:18 16/07/2024 BST			5-day change	1st Jan Change
19.85 ^USD	+0.27%		0.00%	+22.18%

07-03	Kyowa Kirin Buys Back Shares	MT
07-02	Tranche Update on Kyowa Kirin Co., Ltd.'s Equity Buyback Plan announced on February 7, 2024.	CI

Kyowa Kirin Buys Back Shares	07-03	MT
Tranche Update on Kyowa Kirin Co., Ltd.'s Equity Buyback Plan announced on February 7, 2024.	07-02	CI
Ex-dividend day for interim dividend	06-26	FA
Kyowa Kirin Repurchases 3.3 Million Shares in May	06-05	MT
Kyowa Kirin's Profit Up 15% in Q1	05-07	MT
Kyowa Kirin Buys Back Shares for 5.6 Billion Yen in April	05-06	MT
BridgeBio Pharma Shares Decline After Q1 Financial Results	05-02	MT
U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease	04-08	RE
Kyowa Kirin Buys Back 4 Billion Yen Worth of Shares in March	04-03	MT
Tranche Update on Kyowa Kirin Co., Ltd.'s Equity Buyback Plan announced on February 7, 2024.	04-02	CI
Japanese Shares Slip into Red Amid Profit-Taking; Tokyo Inflation Eyed	03-25	MT
Kyowa Kirin to Allocate Over 84,000 Treasury Shares as Director, Officer Compensation	03-25	MT
Kyowa Kirin's gene therapy most expensive US drug with $4.3 million price tag	03-20	RE
US approves first gene therapy for children with rare genetic disease	03-18	RE
US approves first gene therapy for rare genetic disease	03-18	RE
Kyowa Kirin Co., Ltd. to Present Phase 2B Post-Hoc Analysis and Symposium At the American Academy of Dermatology Annual Meeting 2024	03-08	CI
Kyowa Kirin Buys Back Nearly 3 Billion Yen of Shares	03-05	MT
Japan's Nikkei closes at 34-year peak on dovish BOJ; tech shares soar	02-08	RE
Japan's Nikkei leaps to 2-week high on tech stocks, yen boost	02-08	RE
Kyowa Kirin's Profit Up 52% in Fiscal 2023	02-07	MT

No results for this search